The National Public Health Institute of Liberia (NPHIL) has set the record straight, confirming that there is no outbreak of viral hemorrhagic fever (VHF) in Sierra Leone.
Addressing recent rumors, NPHIL’s Director-General, Dr. Dougbeh Chris Nyan, clarified that the situation involved a single suspected case that was promptly investigated and resolved.
“There is no outbreak in Sierra Leone,” Dr. Nyan stressed during a press briefing. He explained that all necessary health protocols were followed, including monitoring contacts for 21 days. “All contacts have been cleared, and there is no cause for alarm.”
The clarification comes after initial reports suggesting an outbreak were widely misinterpreted. Dr. Nyan emphasized that NPHIL had not confirmed any outbreak and had worked with authorities to ensure accurate information reached the public.
Commending Liberia’s healthcare system, Dr. Nyan praised JFK Hospital for its swift response to the suspected case.
“Their proactive measures demonstrate the importance of preparedness in addressing potential health threats,” he said, urging continued vigilance across the region.
Beyond dispelling rumors, Dr. Nyan highlighted Liberia’s strides in improving health security through local vaccine production. NPHIL, in collaboration with local and international partners, is spearheading efforts to establish vaccine manufacturing facilities.
“Producing vaccines locally is crucial for Liberia’s health security,” Dr. Nyan explained. “This initiative will enable faster responses to outbreaks and reduce dependence on external supplies.” He added that the project aligns with Liberia’s broader strategy to strengthen its healthcare system and contribute to regional epidemic preparedness.
Viral hemorrhagic fevers, such as Ebola, Lassa fever, and Marburg virus disease, are severe illnesses that can lead to life-threatening symptoms, including fever, bleeding, and organ failure. Strict isolation protocols and early medical intervention are key to controlling outbreaks.
Dr. Nyan reaffirmed NPHIL’s commitment to safeguarding public health, noting that efforts to enhance Liberia’s disease management capabilities remain a top priority.
He called for continued collaboration between countries in the region to address emerging health threats.
With Liberia’s focus on vaccine production and preparedness, the country is positioning itself as a leader in regional health security while working to protect its citizens from future epidemics.
